| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30000739 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS30031392 | HIV | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
| TVIS44017284 | HTLV-1 | ENSG00000167286.12 | protein_coding | CD3D | No | No | 915 | B0YIY4 P04234 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CD3D |
|---|---|
| DrugBank ID | DB16655 |
| Drug Name | Teclistamab |
| Target ID | BE0010202 |
| UniProt ID | P20963 |
| Regulation Type | antibody |
| PubMed IDs | 32956453 |
| Citations | Pillarisetti K, Powers G, Luistro L, Babich A, Baldwin E, Li Y, Zhang X, Mendonca M, Majewski N, Nanjunda R, Chin D, Packman K, Elsayed Y, Attar R, Gaudet F: Teclistamab is an active T cell-redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma. Blood Adv. 2020 Sep 22;4(18):4538-4549. doi: 10.1182/bloodadvances.2020002393. |
| Groups | Approved; Investigational |
| Direct Classification | Peptides |
| SMILES | |
| Pathways | |
| PharmGKB | |
| ChEMBL |
